C-Reactive Protein Velocity and the Risk of New Onset Atrial Fibrillation among ST Elevation Myocardial Infarction Patients
CONCLUSIONS: CRPv might be an independent and rapidly measurable biomarker for new-onset AF following primary PCI in STEMI patients.PMID:33734630
Source: The Israel Medical Association Journal - Category: General Medicine Authors: David Zahler Ilan Merdler Keren-Lee Rozenfeld Gil Shenberg Assi Milwidsky Shlomo Berliner Shmuel Banai Yaron Arbel Yacov Shacham Source Type: research